Epidemiologic Relationships Between A1C and All-Cause Mortality During a Median 3.4-Year Follow-up of Glycemic Treatment in the ACCORD Trial

作者: M. C. Riddle , W. T. Ambrosius , D. J. Brillon , J. B. Buse , R. P. Byington

DOI: 10.2337/DC09-1278

关键词:

摘要: OBJECTIVE Randomized treatment comparing an intensive glycemic strategy with a standard in the Action to Control Cardiovascular Risk Diabetes (ACCORD) trial was ended early because of unexpected excess mortality arm. As part ongoing post hoc analyses potential mechanisms for this finding, we explored whether on-treatment A1C itself had independent relationship mortality. RESEARCH DESIGN AND METHODS Participants type 2 diabetes ( n = 10,251 mean age 62 years, median duration 10 and 8.1%) were randomly assigned strategies targeting either RESULTS Various characteristics participants study sites at baseline significant associations risk Before after adjustment these covariates, higher average stronger predictor than last interval follow-up or decrease first year. Higher associated greater death. The death increased approximately linearly from 6–9% appeared be only when >7%. CONCLUSIONS These implicate factors persisting levels, rather low per se, as likely contributors ACCORD.

参考文章(20)
Effects of intensive glucose lowering in type 2 diabetes The New England Journal of Medicine. ,vol. 358, pp. 2545- 2559 ,(2008) , 10.1056/NEJMOA0802743
H. C. Gerstein, J. Pogue, J. F. E. Mann, E. Lonn, G. R. Dagenais, M. McQueen, S. Yusuf, , The relationship between dysglycaemia and cardiovascular and renal risk in diabetic and non-diabetic participants in the HOPE study: a prospective epidemiological analysis. Diabetologia. ,vol. 48, pp. 1749- 1755 ,(2005) , 10.1007/S00125-005-1858-4
Paul H. C. Eilers, Brian D. Marx, Flexible smoothing with B-splines and penalties Statistical Science. ,vol. 11, pp. 89- 121 ,(1996) , 10.1214/SS/1038425655
Hertzel C Gerstein, Matthew C Riddle, David M Kendall, Robert M Cohen, Robin Goland, Mark N Feinglos, Julienne K Kirk, Bruce P Hamilton, Faramarz Ismail-Beigi, Patricia Feeney, ACCORD Study Group, None, Glycemia treatment strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. American Journal of Cardiology. ,vol. 99, ,(2007) , 10.1016/J.AMJCARD.2007.03.004
J. Stamler, O. Vaccaro, J. D. Neaton, D. Wentworth, , Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care. ,vol. 16, pp. 434- 444 ,(1993) , 10.2337/DIACARE.16.2.434
M. Wei, S. P. Gaskill, S. M. Haffner, M. P. Stern, Effects of Diabetes and Level of Glycemia on All-Cause and Cardiovascular Mortality: The San Antonio Heart Study Diabetes Care. ,vol. 21, pp. 1167- 1172 ,(1998) , 10.2337/DIACARE.21.7.1167
W. B. Kannel, Diabetes and cardiovascular disease. The Framingham study JAMA: The Journal of the American Medical Association. ,vol. 241, pp. 2035- 2038 ,(1979) , 10.1001/JAMA.241.19.2035
Henry N Ginsberg, Denise E Bonds, Laura C Lovato, John R Crouse, Marshall B Elam, Peter E Linz, Patrick J O’Connor, Lawrence A Leiter, Daniel Weiss, Edward Lipkin, Jerome L Fleg, ACCORD Study Group, None, Evolution of the lipid trial protocol of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. American Journal of Cardiology. ,vol. 99, ,(2007) , 10.1016/J.AMJCARD.2007.03.024
David C Goff Jr, Hertzel C Gerstein, Henry N Ginsberg, William C Cushman, Karen L Margolis, Robert P Byington, John B Buse, Saul Genuth, Jeffrey L Probstfield, Denise G Simons-Morton, ACCORD Study Group, None, Prevention of cardiovascular disease in persons with type 2 diabetes mellitus: current knowledge and rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. American Journal of Cardiology. ,vol. 99, ,(2007) , 10.1016/J.AMJCARD.2007.03.002